News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SCIASCIA THOMAS
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/19/2022 |
4
| SCIASCIA THOMAS (Chief Medical Officer) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $3.21, valued at
$24.1k
|
|
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/15/2022 |
4
| SCIASCIA THOMAS (Chief Medical Officer) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $0.511, valued at
$56.2k
|
|
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/05/2019 |
4
| SCIASCIA THOMAS (Chief Medical Officer) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $10.12, valued at
$506k
|
|
| 05/13/2019 |
4
| SCIASCIA THOMAS (Chief Medical Officer) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Converted 17,118 shares
@ $0
Converted 109,015 preferred shares
@ $0
Converted 13,410 preferred shares
@ $0 |
|
| 05/07/2019 |
3
| SCIASCIA THOMAS (Chief Medical Officer) has filed a Form 3 on Trevi Therapeutics, Inc. |
| 11/08/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/22/2010 |
4
| SCIASCIA THOMAS (SVP Clin Dev & Reg Aff & CMO) has filed a Form 4 on PENWEST PHARMACEUTICALS CO|
Txns:
| Unknown transaction of 40,494 shares
@ $0
Unknown transaction of 45,500 options to buy
@ $2.62, valued at
$119.2k
Unknown transaction of 19,500 options to buy
@ $3.05, valued at
$59.5k
Unknown transaction of 65,000 options to buy
@ $1.56, valued at
$101.4k
Unknown transaction of 75,000 options to buy
@ $3.04, valued at
$228k
|
|
| 03/08/2010 |
4
| SCIASCIA THOMAS (SVP Clin Dev & Reg Aff & CMO) has filed a Form 4 on PENWEST PHARMACEUTICALS CO|
Txns:
| Granted 75,000 options to buy
@ $3.04, valued at
$228k
|
|
|
|